Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Trimipramine
Drug ID BADD_D02294
Description Tricyclic antidepressant similar to imipramine, but with more antihistaminic and sedative properties.
Indications and Usage For the treatment of depression and depression accompanied by anxiety, agitation or sleep disturbance
Marketing Status Prescription; Discontinued
ATC Code N06AA06
DrugBank ID DB00726
KEGG ID D00394
MeSH ID D014299
PubChem ID 5584
TTD Drug ID D00HZV
NDC Product Code Not Available
Synonyms Trimipramine | Trimeprimine | 10,11 Dihydro-N,N,beta-trimethyl-5H-dibenz(b,f)azepine-5-propanamine | Trimipramine, (-)-Isomer | Herphonal | Trimineurin | Novo-Tripramine | Novo Tripramine | NovoTripramine | Nu-Trimipramine | Nu Trimipramine | NuTrimipramine | Rhotrimine | Stangyl | Surmontil | Surmontil Maleate | Trimidura | Trimineurin Maleate | Trimipramin AZU | Trimipramin Beta | Beta, Trimipramin | Trimipramin Stada | Trimipramin-Neurazpharm | Trimipramin Neurazpharm | TrimipraminNeurazpharm | Trimipramine Maleate | Trimipramine Maleate (1:1) | Trimipramine Maleate (1:1), (+)-Isomer | Trimipramine Maleate (1:1), (+-)-Isomer | Trimipramine Maleate (1:1), (-)-Isomer | Trimipramine Mesylate | Trimipramine Monohydrochloride | Trimipramine, (+-)-Isomer | Eldoral | Apo-Trimip | Apo Trimip | ApoTrimip
Chemical Information
Molecular Formula C20H26N2
CAS Registry Number 3564-75-8
SMILES CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Poisoning and toxicityCytochrome P450 2D6P10635T57392Not Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Seizure17.12.03.001--
Sensory loss17.02.07.007--Not Available
Somnolence19.02.05.003; 17.02.04.006--
Stomatitis07.05.06.005--
Tachycardia02.03.02.007--Not Available
Testicular swelling21.13.01.003--Not Available
Thrombocytopenia01.08.01.002--Not Available
Tinnitus17.04.07.004; 04.04.01.002--
Tongue discolouration07.14.02.006--Not Available
Tremor17.01.06.002--
Urinary retention20.02.02.011--
Urticaria23.04.02.001; 10.01.06.001--
Vascular purpura01.01.04.007; 24.07.06.011; 23.06.01.008--Not Available
Vision blurred17.17.01.010; 06.02.06.007--
Vomiting07.01.07.003--
Weight increased13.15.01.006--
Acute coronary syndrome24.04.04.011; 02.02.02.015--Not Available
Inappropriate antidiuretic hormone secretion14.05.07.001; 05.03.03.001--Not Available
Disturbance in sexual arousal19.08.04.003--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
Erectile dysfunction21.03.01.007; 19.08.04.001--
Ill-defined disorder08.01.03.049--Not Available
Psychotic disorder19.03.01.002--
Bone marrow failure01.03.03.005--
Oropharyngeal discomfort22.02.05.027; 07.05.05.008--Not Available
Oropharyngeal pain22.02.05.022; 07.05.05.004--
The 3th Page    First    Pre   3    Total 3 Pages